US medtech industry pushes for final rule on global GCPs before FDA completes foreign study guidance
This article was originally published in SRA
Executive Summary
Medical device makers in the US are concerned about a lack of globally harmonized standards for good clinical practices, which they say could cause problems for a guidance that the Food and Drug Administration has drafted on studies conducted outside the US.